The healthcare industry is changing and we have the breadth of expertise to help you evolve with it.
Comprehensive service offerings at every point in the product life cycle.
A platform of digital products to improve, simplify and automate RA/QA activities
Emergo by UL's new human factors tool - provides training, tools, and resources.
Our software tools offer digital regulatory monitoring for medical device compliance and access to human factors engineering tools.
The latest industry news and insights from our global team.
Stay informed with the most read RA/QA medical device newsletter.
TalkingPoints is a round-up of news, insights, and resources about human factors and usability for medical devices, IVDs, combination products, and more.
Information and tools to advance your business.
Learn from our experts through live events.
Our global consulting team works from 20+ offices on six continents.
The demand for combination products continues to grow. We partner with combination product developers to overcome regulatory challenges as well as design safer, more effective products that help deliver more personalized and precise care.
We'd like to help you find what you are looking for. Please try again with a different term or contact our Customer Support team.
The latest industry insights from our global team.
FDA released new Q&A-style guidance document finalizing 2016 HFE draft guidance for combination products
An overview of Emergo by UL’s approach to knowledge tasks to align with FDA expectations.
Recent surveys of IVD manufacturers in the European Union show slow transitions to IVDR compliance
New innovation program provides incentives for French companies to conduct research and development through accredited organizations including Emergo by UL
This process chart illustrates the COFEPRIS approval process per device classification in Mexico and is available for download in the Regulatory Affairs Management Suite (RAMS).
The UK's withdrawal from the European Union has major ramifications for medical device manufacturers, including in-country representation requirements for companies selling their devices in Great Britain.
This process chart illustrates the ANVISA approval process per device classification in Brazil and is available for download in the Regulatory Affairs Management Suite (RAMS).
As medical devices adopt more advanced technologies, their reliance on software has been increasing.
Thanks for your interest in our products and services. Let's collect some information so we can connect you with the right person.
We'll review your message carefully and get back to you as quickly as possible. To help ensure that you receive our reply, please add our domain @emergo.ul.com to your list of approved contacts.